The Hematology Clinical Research Training Program at the University of Pennsylvania was established in 1978 and has provided training for 132 men and women. The program's primary goal is to help a diverse group of individuals prepare for careers as investigators in the broadly-defined discipline of hematology and blood disorders. The faculty includes 37 trainers of all academic ranks and a plan is in place for adding or withdrawing trainers when appropriate. Up to 12 new trainees are accepted each year (8 postdocs and 4 predocs). Candidates were originally were drawn primarily from physicians enrolled in the clinical hematology training programs in the Departments of Medicine and Pediatrics. Since 1998 we have also supported postdoctoral trainees who are not physicians and, since 2004, predoctoral trainees, most of whom are in Penn's MD-PhD program. The connection to the MD-PhD program takes advantage of the PI's role as the director of that program. The inclusion of predoctoral students reflects our belief in the long term value of involving talented students to hematology-related research at an earlier point in their training as scientists and physician-scientists. Essential features of the program include formal and informal advising, skills workshops, attendance at local seminars and national conferences, coursework, training in the responsible conduct of research, and an annual symposium. MD postdoctoral fellows have the option of enrolling in a Biomedical Graduate Studies (BGS) PhD program. Outcomes. 117 postdoctoral trainees (68 MD, 17 MD-PhD and 32 PhD) and 15 pre-doctoral trainees (10 MD-PhD and 5 PhD) have been supported. Of the 109 who have completed all stages of training, 56 (50%) hold full-time appointments at an academic institution, 13 (12%) are employed in industry, 1 (1%) works at the FDA, and 3 (3%) run transfusion services at the NIH or Red Cross (total 67%), all of which we consider appropriate outcomes. Of those who currently hold fulltime academic appointments, at least 68% currently hold or have had NIH research funding. A detailed plan for attracting and training a diverse group of men and women, monitoring their progress benchmarked with an individualized development plan, and receiving feedback from trainees, alumni and faculty is included in the application.

Public Health Relevance

Hematology Clinical Research Training Program (T32 HL-07439) PI: Brass, Lawrence F. PROJECT NARRATIVE As the pace at which biomedical research advances increases, there is a greater need than ever for physician-scientists and scientists who are trained to work at the intersection between medicine and science. The goal of the Hematology Clinical Research Training Program is to identify, train and mentor a diverse group of outstanding men and women and to help them become teachers, scholars, and leaders of biomedical research in academia and industry with an emphasis on fields of endeavor that are applicable to the broad range of hematology.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Evans, Rebecca A; Diamond, Mark S; Rech, Andrew J et al. (2016) Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. JCI Insight 1:
Tasian, S K; Hurtz, C; Wertheim, G B et al. (2016) High incidence of philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) in older adults with B-ALL. Leukemia :
Khoshnejad, Makan; Shuvaev, Vladimir V; Pulsipher, Katherine W et al. (2016) Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles. Bioconjug Chem 27:628-37
Greineder, Colin F; Hood, Elizabeth D; Yao, Anning et al. (2016) Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans. J Control Release 226:229-37
Stonestrom, Aaron J; Hsu, Sarah C; Werner, Michael T et al. (2016) Erythropoiesis provides a BRD's eye view of BET protein function. Drug Discov Today Technol 19:23-28
Girard, Romuald; Zeineddine, Hussein A; Orsbon, Courtney et al. (2016) Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease. J Neurosci Methods 271:14-24
Zhu, S; Welsh, J D; Brass, L F et al. (2016) Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow. J Thromb Haemost 14:1070-81
Zhou, Zinan; Tang, Alan T; Wong, Weng-Yew et al. (2016) Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 532:122-6
Edwards, Christopher R; Ritchie, William; Wong, Justin J-L et al. (2016) A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. Blood :
Welsh, John D; Muthard, Ryan W; Stalker, Timothy J et al. (2016) A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature. Blood 127:1598-605

Showing the most recent 10 out of 93 publications